Overview

AVANDAMET Versus Metformin For Type 2 Diabetes Mellitus

Status:
Completed
Trial end date:
2005-12-16
Target enrollment:
Participant gender:
Summary
This 48-week study will compare AVANDAMET vs. Metformin monotherapy for blood glucose control in patients with Type 2 Diabetes Mellitus.
Phase:
Phase 4
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Metformin
Rosiglitazone